The diagnostics industry is buzzing with excitement as Gradientech, alongside its Italian distributor a.d.a. SRL, clinches two pivotal tenders for their revolutionary QuickMIC system. This major win sees the QuickMIC systems being embraced by two renowned Italian hospitals, Azienda USL Valle d’Aosta in Aosta and P.O. Michele e Pietro Ferrero in Alba. These hospitals will soon integrate QuickMIC into their clinical workflow, a move anticipated to enhance the management of sepsis with cutting-edge precision.
Revolutionary Technology for Rapid Results
QuickMIC stands out in the world of diagnostics for its ultra-rapid antibiotic susceptibility testing (AST) capabilities. Designed to deliver precise results in merely 2-4 hours, QuickMIC is tailored to aid clinicians in making more informed antibiotic decisions promptly. Its modular design offers the flexibility for scale, an appealing feature for both small and large hospital laboratories.
A Significant Milestone in European Expansion
According to SelectScience, this successful venture marks a crucial milestone in Gradientech’s strategy to expand its presence across Europe. The Italian market is proving to be an innovator in rapid AST diagnostics, setting new standards in sepsis management. “Winning these tenders is a strong endorsement of our technology,” states Sara Thorslund, CEO and co-founder of Gradientech, celebrating the success.
Strategic Impact on Infectious Disease Management
The integration of QuickMIC within these hospitals represents more than a business victory; it signifies a leap forward in the fight against infectious diseases and antimicrobial resistance. Highlighting the strategic importance, Andrea Grillo, Managing Director of a.d.a. SRL, remarks on the critical role of rapid AST in effective treatment adjustment.
The Road Ahead
This Italian endeavor not only underscores Gradientech’s commitment to advancing diagnostics but also sets a new benchmark for rapid AST deployment in healthcare. With QuickMIC already making waves in Europe, the next steps in its global expansion journey are eagerly awaited.
With such promising technological strides, Gradientech continues to shape the future of diagnostics—one rapid test at a time.
